Pancreatic Cancer Research

ResearcherKumamoto UniversityNo recent work listed

Masayo Tsukamoto

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5103613667. Sources: OpenAlex.

Their work

Papers
8
Trials
0
Grants
0
Labs led
0
Collaborators
27
Papers, trials and grants by year

2018: 3 papers · 2019: 2 papers · 2020: 1 paper · 2021: 1 paper · 2022: none · 2023: 1 paper

Papers 8

  1. The Prognostic Role of Serine Racemase in Patients With Pancreatic Cancer: A New Marker in Cancer Metabolism. Co-author DOI 10.1097/mpa.0000000000002210↗
  2. Prognostic Value of the Preoperative Tumor Marker Index in Resected Pancreatic Ductal Adenocarcinoma: A Retrospective Single-Institution Study. Co-author DOI 10.1245/s10434-020-09022-3↗
  3. Postoperative nonalcoholic fatty liver disease is correlated with malnutrition leading to an unpreferable clinical course for pancreatic cancer patients underg… Co-author DOI 10.1007/s00595-019-01866-x↗
  4. PD-L1 expression enhancement by infiltrating macrophage-derived tumor necrosis factor-α leads to poor pancreatic cancer prognosis. Co-author DOI 10.1111/cas.13874↗
  5. Cellular Senescence, Represented by Expression of Caveolin-1, in Cancer-Associated Fibroblasts Promotes Tumor Invasion in Pancreatic Cancer. Co-author DOI 10.1245/s10434-019-07266-2↗
  6. Clinical usefulness of postoperative C-reactive protein/albumin ratio in pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.amjsurg.2017.08.016↗
  7. Downregulation of 15-hydroxyprostaglandin dehydrogenase by interleukin-1β from activated macrophages leads to poor prognosis in pancreatic cancer. Co-author DOI 10.1111/cas.13467↗
  8. Cystic gastric metastasis from pancreatic cancer. Co-author DOI 10.1186/s40792-018-0443-2↗

Closest collaborators

The 25 strongest of 27 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Katsunori Imai · 7 shared papers, 2018–2023 · strength 0.68
  2. Shigeki Nakagawa · 6 shared papers, 2018–2023 · strength 0.55
  3. Takanobu Yamao · 6 shared papers, 2018–2021 · strength 0.52
  4. Hideo Baba · 5 shared papers, 2018–2023 · strength 0.50
  5. Hirohisa Okabe · 6 shared papers, 2018–2021 · strength 0.49
  6. Akira Chikamoto · 6 shared papers, 2018–2021 · strength 0.49
  7. Hiromitsu Hayashi · 4 shared papers, 2019–2023 · strength 0.47
  8. Tatsunori Miyata · 5 shared papers, 2018–2021 · strength 0.42
  9. Kota Arima · 5 shared papers, 2018–2020 · strength 0.37
  10. Naoki Umezaki · 4 shared papers, 2018–2020 · strength 0.31
  11. Yuki Kitano · 4 shared papers, 2018–2020 · strength 0.31
  12. Yosuke Nakao · 3 shared papers, 2019–2021 · strength 0.30
  13. Rumi Itoyama · 3 shared papers, 2018–2021 · strength 0.27
  14. Kensuke Yamamura · 3 shared papers, 2018–2019 · strength 0.23
  15. Takatsugu Ishimoto · 3 shared papers, 2018–2019 · strength 0.21
  16. Daisuke Hashimoto · 3 shared papers, 2018 · strength 0.21
  17. Kosuke Mima · 1 shared paper, 2023 · strength 0.17
  18. Chuan Lan · 1 shared paper, 2023 · strength 0.17
  19. Takayoshi Kaida · 1 shared paper, 2023 · strength 0.17
  20. Zhao Liu · 1 shared paper, 2023 · strength 0.17
  21. Hideo Baba · 2 shared papers, 2018 · strength 0.14
  22. Hideo Andreas Baba · 1 shared paper, 2021 · strength 0.12
  23. Kazuki Matsumura · 1 shared paper, 2021 · strength 0.12
  24. Hirohisa Okabe · 1 shared paper, 2020 · strength 0.09
  25. Masahiko Hirota · 1 shared paper, 2019 · strength 0.08

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.